O
MDCO

OppenheimerFunds’s Medicines Co MDCO Stock Holding History

OppenheimerFunds’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-708,223
Closed -$21.2M – 1884
2018
Q3 		$21.2M Buy
708,223
+1,063
+0.2% +$40K 0.02% 571
2018
Q2 		$26M Buy
707,160
+1,777
+0.3% +$57.7K 0.03% 517
2018
Q1 		$23.2M Sell
705,383
-3,451
-0.5% -$108K 0.03% 531
2017
Q4 		$19.4M Sell
708,834
-4,893
-0.7% -$151K 0.02% 597
2017
Q3 		$26.4M Sell
713,727
-299
-0% -$11K 0.03% 478
2017
Q2 		$27.1M Buy
714,026
+97,824
+16% +$4.36M 0.03% 457
2017
Q1 		$30.1M Sell
616,202
-729
-0.1% -$33.2K 0.04% 444
2016
Q4 		$20.9M Buy
616,931
+1,971
+0.3% +$69.9K 0.03% 563
2016
Q3 		$23.2M Buy
614,960
+608,090
+8,851% +$22.9M 0.03% 530
2016
Q2 		$231K Sell
6,870
-623
-8% -$22K ﹤0.01% 1565
2016
Q1 		$238K Sell
7,493
-719
-9% -$23.5K ﹤0.01% 1540
2015
Q4 		$307K Buy
+8,212
New +$310K ﹤0.01% 1505
2014
Q1 		– Sell
-485,140
Closed -$18.7M – 980
2013
Q4 		$18.7M Buy
485,140
+45,170
+10% +$1.62M 0.02% 577
2013
Q3 		$14.7M Sell
439,970
-148,720
-25% -$4.74M 0.02% 618
2013
Q2 		$18.1M Buy
+588,690
New +$19.7M 0.03% 533

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

OppenheimerFunds's MDCO Position: Q4 2018 in Review

OppenheimerFunds sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 708,223 shares — an estimated $21.2M sold.

OppenheimerFunds first reported a position in MDCO in Q2 2013 and held it in 15 quarters. The position peaked at $30.1M in Q1 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • OppenheimerFunds reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • OppenheimerFunds sold 708,223 Medicines Co shares in Q4 2018, an estimated $21.2M.
  • OppenheimerFunds first reported a position in Medicines Co in Q2 2013 and held it in 15 quarters.
  • OppenheimerFunds's Medicines Co position peaked at $30.1M in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.